Lupus

Unraveling the Diagnostic Process for Lupus

Lupus is a chronic autoimmune condition in which the immune system mistakenly attacks the body’s own tissues and organs. This can lead to inflammation affecting the joints, skin, kidneys, blood cells, brain, heart, and lungs. Lupus is more common than you might think, affecting millions worldwide with a higher incidence among women, particularly those of reproductive age. (Source

Diagnosing lupus is complex. The symptoms of lupus are diverse and often mimic those of other diseases, such as rheumatoid arthritis or undifferentiated connective tissue disease, leading to potential misdiagnosis or delayed diagnosis. Common symptoms such as fatigue, joint pain, and rashes can easily be attributed to less severe health issues, which is why lupus is often referred to as “the great imitator.” (Source, Source)

Understanding your diagnosis sets the stage for your personalized treatment plan tailored to your needs and health goals. In this guide, we aim to provide a comprehensive overview of the diagnostic process and tests used for lupus. 

Beginning Your Diagnostic Journey

Diagnosing lupus usually begins with a comprehensive initial assessment, where your health care provider delves into your medical and family histories, and may also perform a physical examination. 

Medical History

Your medical history provides crucial clues that can aid with the diagnosis of lupus. This includes a detailed account of symptoms — their onset, duration, and pattern — and any previous diagnoses or treatments. It’s important to share as much as you can with your health care provider, as even seemingly minor details can be significant. (Source)

Family History

A family history of lupus or other autoimmune diseases can be a significant piece of the diagnostic puzzle, suggesting a genetic predisposition. While having a family member with lupus doesn’t guarantee you’ll have it, this information can guide your health care provider in their diagnostic process. (Source)

Physical Examination: More Than Meets the Eye

Physical examination is a critical step. Health care providers look for key physical signs indicative of lupus. This includes examining the skin and joints, two areas commonly affected by the disease.

  • skin examination: The hallmark butterfly rash across the cheeks and nose is a classic lupus sign, but there are other skin manifestations too. Your provider will look for rashes, lesions, or other skin changes that might suggest lupus.
  • joint examination: Swelling, tenderness, or pain in the joints can be signs of lupus. Your health care provider will assess these symptoms, considering their pattern and severity.

(Source, Source)

Laboratory Tests and Their Significance

Laboratory tests are cornerstones in the diagnosis of lupus, offering invaluable insights into the body’s inner workings. Let's explore these tests and understand their significance in the diagnosis of lupus.

Complete Blood Count (CBC)

The CBC is a fundamental test that provides a snapshot of your blood health. It can reveal: 

  • anemia: a low red blood cell count
  • leukopenia: low white blood cell count
  • thrombocytopenia: low platelet count  

All of these can be indicators of lupus. These findings, while not exclusive to lupus, when considered alongside other symptoms and test results can support a lupus diagnosis. (Source)

Erythrocyte Sedimentation Rate (ESR)

The ESR test measures how quickly red blood cells settle at the bottom of a test tube. A faster rate can indicate inflammation in the body, a common feature in lupus. The ESR isn't specific to any one disease — it may be elevated if you have lupus, or any other inflammatory condition. (Source)

Antinuclear Antibody (ANA) Test

Antinuclear antibodies are antibodies that attack substances and structures inside cells, especially the nucleus, where DNA is found. Having a positive ANA test has been linked to a number of autoimmune diseases, but ANAs may also be detected in healthy people. Testing for them can help rule out other diagnoses but will need to be used with your medical history, symptoms, and other tests in order to confirm a diagnosis. (Source, Source)

Urinalysis: A Look at Kidney Health

Lupus can affect the kidneys and urinalysis, or testing of the urine, helps detect this. The presence of protein (proteinuria) or blood (hematuria) in the urine can be signs of lupus affecting parts of the kidney that filter out waste. (Source)

Additional Blood Tests: Beyond the Basics

Other tests, such as those for anti-double stranded DNA and anti-Smith antibodies can also be used to confirm a lupus diagnosis and monitor disease activity. (Source, Source)

Advanced Diagnostic Tools

Imaging tools such as ultrasound and MRI play crucial roles in evaluating organ involvement in lupus. These tools help visualize internal structures, providing valuable information about the condition of organs potentially affected by lupus.

  • ultrasound: This non-invasive technique can help detect joint inflammation, regardless of whether or not you’re experiencing joint pain. (Source)
  • MRI: MRI offers detailed images of organs and tissues, crucial for assessing the extent of organ involvement in lupus, especially in the central nervous system. (Source)

The Role of Tissue Biopsies

Tissue biopsies are instrumental in confirming organ involvement in lupus. By examining a small tissue sample under a microscope, health care professionals can detect changes specific to lupus.

  • kidney biopsy: A kidney biopsy is a definitive method for diagnosing lupus nephritis (when lupus affects the kidneys). It helps determine the severity of kidney involvement, guiding treatment decisions. (Source)
  • skin biopsy: For patients with skin manifestations, a skin biopsy can confirm cutaneous lupus erythematosus. It helps differentiate lupus-related skin changes from other skin conditions. (Source)

Challenges and Considerations in Lupus Diagnosis

Distinguishing lupus from other autoimmune diseases can be challenging due to overlapping symptoms. Lupus can mimic conditions such as rheumatoid arthritis, Sjögren’s syndrome, and celiac disease, making accurate diagnosis a complex process. (Source, Source)

  • similar symptoms: Many autoimmune diseases share common symptoms such as joint pain, fatigue, and skin rashes. This similarity can lead to initial misdiagnosis or delayed diagnosis. (Source)
  • laboratory tests: Specific tests, such as the ANA test, are helpful but do not confirm diagnosis of lupus. A positive ANA test can occur in other autoimmune diseases, so further testing is needed. (Source)

Evolving Criteria for Lupus Diagnosis

The criteria for diagnosing lupus have evolved over time, with the American College of Rheumatology (ACR), the Systemic Lupus International Collaborating Clinics (SLICC), and the European League Against Rheumatism (EULAR) providing guidelines.

  • ACR criteria: Initially developed in 1982 and revised in 1997, the ACR criteria include symptoms and laboratory findings specific to lupus. (Source)
  • SLICC criteria: Introduced in 2012, the SLICC criteria provide a more comprehensive approach, including more dermatological and neurological manifestations. (Source)
  • EULAR/ACR criteria: This international initiative developed new classification criteria that were released in 2019. It includes additional skin manifestations and laboratory testing to reflect our better understanding of lupus. (Source)

Living With Lupus: Beyond Diagnosis

Living with lupus extends far beyond the initial diagnosis. It involves nurturing your body and mind, and building a supportive community around you.

  • nutrition's role: A diet rich in nutrient-dense, anti-inflammatory foods can help manage symptoms and improve overall health. (Source)
  • stress management: Stress can worsen lupus symptoms. Techniques such as mindfulness, yoga, and meditation have been shown to reduce stress and improve quality of life in lupus patients. (Source)
  • community support: Joining lupus support groups, either in person or online, can provide emotional support and practical advice. Sharing experiences with others who understand can be incredibly empowering. (Source)

Ongoing monitoring and treatment adjustments are crucial in managing lupus effectively. Regular communication and visits to your health care provider are essential for monitoring the progression of your disease as well as making sure your treatment plan fits your current needs and health goals.

The Bottom Line

Getting a lupus diagnosis is a complex process — it brings together your medical and family histories, laboratory tests, and imaging studies. Understanding the diagnostic process of lupus, and the challenges that comes with it, is an important tool when it comes to managing this disease. Identifying symptoms early and getting a timely diagnosis can reduce the risk of future health complications and improve your quality of life. 

References

Aringer, M., Costenbader, K., Daikh, D., Brinks, R., Mosca, M., Ramsey-Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D. T., Kamen, D. L., Jayne, D., Cervera, R., Costedoat-Chalumeau, N., Diamond, B., Gladman, D. D., Hahn, B., Hiepe, F., Jacobsen, S., Khanna, D., … Johnson, S. R. (2019). 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis & Rheumatology, 71(9), 1400–1412. https://doi.org/10.1002/art.40930

Bloch, D. B. (2021, June 23). Patient education: Antinuclear antibodies (ANA) (Beyond the Basics). UpToDate. Retrieved November 22, 2023, from https://www.uptodate.com/contents/antinuclear-antibodies-ana-beyond-the-basics

Bruce, I. N., Buie, J., Bloch, L., Bae, S.-C., Costenbader, K., Levy, R. A., Werth, V. P., Marion, A., Sangodkar, S., & Manzi, S. (2023). Lupus spectrum ambiguity has long-term negative implications for patients. Lupus Science & Medicine, 10(1), e000856. https://doi.org/10.1136/lupus-2022-000856

Gergianaki, I., & Bertsias, G. (2018). Systemic lupus erythematosus in primary care: An update and practical messages for the general practitioner. Frontiers in Medicine, 5, 161. https://www.frontiersin.org/articles/10.3389/fmed.2018.00161

Hochberg, M. C. (1997). Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis & Rheumatism, 40(9), 1725–1725. https://doi.org/10.1002/art.1780400928

Islam, M. A., Khandker, S. S., Kotyla, P. J., & Hassan, R. (2020). Immunomodulatory effects of diet and nutrients in systemic lupus erythematosus (SLE): A systematic review. Frontiers in Immunology, 11, 1477. https://doi.org/10.3389/fimmu.2020.01477

Justiz Vaillant, A. A., Goyal, A., & Varacallo, M. (2023). Systemic lupus erythematosus. StatPearls [Internet]. Retrieved November 22, 2023, from http://www.ncbi.nlm.nih.gov/books/NBK535405/

Kernder, A., Richter, J. G., Fischer-Betz, R., Winkler-Rohlfing, B., Brinks, R., Aringer, M., Schneider, M., & Chehab, G. (2021). Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: Cross sectional analysis of the LuLa cohort. Lupus, 30(3), 431–438. https://doi.org/10.1177/0961203320983445

Ludmann, P. (2022, September 23a). Lupus and your skin: Diagnosis and treatment. American Academy of Dermatology Association. https://www.aad.org/public/diseases/a-z/lupus-treatment

Ludmann, P. (2022, September 23b). Lupus and your skin: Signs and symptoms. American Academy of Dermatology Association. https://www.aad.org/public/diseases/a-z/lupus-symptoms

Lupus Foundation of America. (n.d.). Common diseases that overlap with lupus. https://www.lupus.org/resources/common-diseases-that-overlap-with-lupus

MedlinePlus. (n.d.-a). CBC blood test. National Institutes of Health, National Library of Medicine,  https://medlineplus.gov/ency/article/003642.htm

MedlinePlus. (n.d.-b). ESR. National Institutes of Health, National Library of Medicine. https://medlineplus.gov/ency/article/003638.htm

Mizukami, A., Trinh, M. T., Hoang, T. P., Shibanuma, A., Ong, K. I. C., & Jimba, M. (2023). Determinants of health-related quality of life among patients with systemic lupus erythematosus in Hanoi, Vietnam. BMC Rheumatology, 7(1), 16. https://doi.org/10.1186/s41927-023-00339-6

National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.). Lupus and kidney disease (lupus nephritis). U.S. Department of Health and Human Services, National Institutes of Health. https://www.niddk.nih.gov/health-information/kidney-disease/lupus-nephritis

Petri, M., Naqibuddin, M., Carson, K. A., Wallace, D. J., Weisman, M. H., Holliday, S. L., Sampedro, M., Narayana, S., Fox, P. T., Franklin, C., Padilla, P. A., & Brey, R. L. (2008). Brain Magnetic Resonance Imaging in Newly Diagnosed Systemic Lupus Erythematosus. The Journal of Rheumatology, 35(12), 2348–2354.

Petri, M., Orbai, A.-M., Alarcón, G. S., Gordon, C., Merrill, J.T ., Fortin, P. R., Bruce, I. N., Isenberg, D., Wallace, D. J., Nived, O., Sturfelt, G., Ramsey-Goldman, R., Bae, S.-C., Hanly, J. G., Sánchez-Guerrero, J., Clarke, A., Aranow, C., Manzi, S., Urowitz, M., . . . Magder, L. S. (2012). Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis & Rheumatism, 64, 2677–2686. https://doi.org/10.1002/art.34473

Rovin, B. H., Parikh, S., & Alvarado, A. (2014). The kidney biopsy in lupus nephritis: Is it still relevant? Rheumatic Diseases Clinics of North America, 40(3), 537–ix. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145529/

Ruano, C. A., Malheiro, R., Oliveira, J. F., Pinheiro, S., Vieira, L. S., & Moraes-Fontes, M. F. (2017). Ultrasound detects subclinical joint inflammation in the hands and wrists of patients with systemic lupus erythematosus without musculoskeletal symptoms. Lupus Science & Medicine, 4(1), e000184. https://doi.org/10.1136/lupus-2016-000184

Suurmond, J., & Diamond, B. (2015). Autoantibodies in systemic autoimmune diseases: Specificity and pathogenicity. Journal of Clinical Investigation, 125(6), 2194–2202. https://doi.org/10.1172/JCI78084

Taub, R., Horesh, D., Rubin, N., Glick, I., Reem, O., Shriqui, G., & Agmon-Levin, N. (2021). Mindfulness-based stress reduction for systemic lupus erythematosus: A mixed-methods pilot randomized controlled trial of an adapted protocol. Journal of Clinical Medicine, 10(19), 4450. https://doi.org/10.3390/jcm10194450

Ulff-Møller, C. J., Simonsen, J., Kyvik, K. O., Jacobsen, S., & Frisch, M. (2017). Family history of systemic lupus erythematosus and risk of autoimmune disease: Nationwide Cohort Study in Denmark 1977–2013. Rheumatology, 56(6), 957–964. https://doi.org/10.1093/rheumatology/kex005

Wang, X., & Xia, Y. (2019a). Anti-double stranded DNA antibodies: Origin, pathogenicity, and targeted therapies. Frontiers in Immunology, 10, 3389. https://www.frontiersin.org/articles/10.3389/fimmu.2019.01667